Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […]

» Read more

Infliximab Weakens COVID Antibody Response for Patients With IBD

Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […]

» Read more

Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function

The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, […]

» Read more
1 14 15 16 17 18 39